HOXB5 overexpression is associated with neuroendocrine differentiation and poor prognosis in prostate cancer
| Main Author: | sekino yohei |
|---|---|
| Format: | Article Journal |
| Terbitan: |
, 2021
|
| Online Access: |
https://zenodo.org/record/4898534 |
Daftar Isi:
- Supplementary Table 1 Clinicopathologic characteristics of 128 PCa patients who were treated with radical prostatectomy. Supplementary Table 2 Clinicopathologic characteristics of 74 with metastatic PCa with androgen deprivation therapy Supplementary figure 1 The expression of HOXB5 from GSE147250 (A) HOXB5 expression in control, RB1 knockout, TP53 knockout, and double (RB1/TP53) knockout cells in LNCaP. KO: knockout, DKO: double knockout (B) HOXB5 expression in control, and double (RB1/TP53) knockout cells in LNCaP treated with enzalutamide. DKO: double knockout Supplementary Information RNA interference, Western blotting, cell growth and invasion assays, and statistical analysis are described in detail in the Supplementary information section.